CARBAMAZEPINE INDUCED SLE-A RARE AND SERIOUS ADR | Zendy

Sai Keerthana P. C. | Zendy; K N Anila | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CARBAMAZEPINE INDUCED SLE-A RARE AND SERIOUS ADR

Author(s) -

Sai Keerthana P. C.,

K N Anila

Publication year - 2016

Publication title -

international journal of pharmacy and pharmaceutical sciences

Language(s) - English

Resource type - Journals

eISSN - 2656-0097

pISSN - 0975-1491

DOI - 10.22159/ijpps.2017v9i1.14630

Subject(s) - carbamazepine , medicine , drug , systemic lupus erythematosus , pharmacology , lupus erythematosus , immunology , disease , epilepsy , psychiatry , antibody

Carbamazepine is a commonly used antiseizure medication. Carbamazepine-induced SLE (Systemic Lupus Erythematosus) is a very rare phenomenon. Drug-induced SLE is an autoimmune disease caused by long-term use of certain drugs. Carbamazepine is a drug with low risk for causing lupus symptoms. The process that leads to drug-induced SLE are not entirely understood. A very few cases are reported with carbamazepine association with SLE. Herein we report a case of 4 y old girl with SLE induced by carbamazepine showing a causality score of 8 by Naranjo ADR probability scale.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research